| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.900 | 29.445 | 31.288 | 40.747 | 50.865 | 71.576 | 72.327 | 76.766 | 76.592 | 76.062 |
| Total Income - EUR | 23.901 | 29.446 | 31.289 | 40.747 | 50.865 | 71.601 | 72.331 | 76.773 | 76.596 | 76.055 |
| Total Expenses - EUR | 11.811 | 15.952 | 15.413 | 15.278 | 21.371 | 24.145 | 24.453 | 24.584 | 30.064 | 31.552 |
| Gross Profit/Loss - EUR | 12.090 | 13.493 | 15.876 | 25.469 | 29.494 | 47.456 | 47.878 | 52.189 | 46.531 | 44.503 |
| Net Profit/Loss - EUR | 11.373 | 13.199 | 15.563 | 25.061 | 28.985 | 46.930 | 47.169 | 51.421 | 46.145 | 42.221 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Macrismedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 202 | 782 | 514 | 62 | 403 | 647 | 272 | 886 | 904 | 1.314 |
| Current Assets | 10.700 | 13.280 | 16.008 | 26.051 | 29.807 | 47.432 | 50.199 | 55.653 | 57.708 | 54.107 |
| Inventories | 0 | 0 | 0 | 361 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.102 | 2.200 | 2.298 | 5.577 | 7.726 | 6.090 | 8.244 | 39.063 | 37.434 | 30.751 |
| Cash | 8.597 | 11.081 | 13.710 | 20.112 | 22.081 | 41.343 | 41.955 | 16.589 | 20.275 | 23.356 |
| Shareholders Funds | 10.050 | 13.252 | 15.616 | 25.113 | 29.036 | 46.980 | 47.218 | 51.470 | 46.194 | 42.269 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 852 | 810 | 906 | 1.000 | 1.175 | 1.099 | 3.254 | 5.069 | 12.418 | 13.152 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Macrismedica Srl